Concepedia

Melinda Iliopoulos

MI

Statistics

Publications

5

Citations

162

H-Index

5

Active since

2021

Affiliations

The University of Melbourne(Current)

Walter and Eliza Hall Institute of Medical Research

La Trobe University

Royal Children's Hospital

The University of Adelaide

Melinda Iliopoulos is an author at The University of Melbourne specializing in oncology, medicine, and chimeric antigen receptor t-cell therapy.

ORCID

Publications per year

2021–2024

5

Publications

5

BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells

Diane Moujalled, Adam Southon, Kerstin Brinkmann et al. · Cell Death and Differentiation · 2022 · 56 citations · Full text

, , +17

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma

Rebecca C Abbott, Daniel J. Verdon, Fiona M. Gracey et al. · Clinical & Translational Immunology · 2021 · 43 citations · Full text

, , +17

HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma

Stacie Shiqi Wang, Alexander J. Davenport, Melinda Iliopoulos et al. · Neuro-Oncology Advances · 2023 · 26 citations · Full text

, , +17

EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses

Leesa Lertsumitkul, Melinda Iliopoulos, Stacie Shiqi Wang et al. · Journal for ImmunoTherapy of Cancer · 2024 · 22 citations · Full text

, , +17

Human <scp>EGFRvIII</scp> chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma

Rebecca C Abbott, Melinda Iliopoulos, Katherine A. Watson et al. · Clinical & Translational Immunology · 2023 · 15 citations · Full text

, , +17

1–5 of 5